Orthocell MD, Paul Anderson, presented at the Canaccord Genuity South-West Connect ASX Showcase today to share the latest news and developments for the Company’s Ortho-ATI™ and CelGro™ platform technologies.
It was a terrific opportunity to promote the promising and maturing investment opportunities within Orthocell’s regenerative medicine product portfolio.